Which has higher immunization, hib3, Antigua and Barbuda or Monaco?

Antigua and Barbuda, at 99.0% against 99.0% in Monaco as of 2024.

What is the difference in immunization, hib3 between Antigua and Barbuda and Monaco?

0.0%, with Antigua and Barbuda ahead.

How many years of comparable data are there for Antigua and Barbuda and Monaco?

24 years are reported by both, from 2001 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Antigua and Barbuda vs Monaco: Immunization, Hib3

Antigua and Barbuda

99.0%

in 2024

Monaco

99.0%

in 2024

Antigua and Barbuda rank

1st

Monaco rank

1st

Immunization, Hib3 over time

Antigua and Barbuda
Monaco

How they compare

Antigua and Barbuda currently reports 99.0% against 99.0% in Monaco, a difference of 0.0%.

Across all 24 years both countries report, Monaco has been ahead every year.

Antigua and Barbuda ranks 1st and Monaco ranks 1st of 191 countries.

Monaco has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Antigua and Barbuda	Monaco	Difference	Ahead
2000s	97.3%	99.0%	1.7%	Monaco
2010s	97.3%	99.0%	1.7%	Monaco
2020s	97.4%	99.0%	1.6%	Monaco

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Antigua and Barbuda or Monaco?: Antigua and Barbuda, at 99.0% against 99.0% in Monaco as of 2024.
What is the difference in immunization, hib3 between Antigua and Barbuda and Monaco?: 0.0%, with Antigua and Barbuda ahead.
How many years of comparable data are there for Antigua and Barbuda and Monaco?: 24 years are reported by both, from 2001 to 2024.
How do Antigua and Barbuda and Monaco rank globally for immunization, hib3?: Antigua and Barbuda ranks 1st and Monaco ranks 1st of 191 countries.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Antigua and Barbuda vs Monaco: Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 15 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/antigua-and-barbuda/monaco/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/antigua-and-barbuda/monaco/">Antigua and Barbuda vs Monaco: Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 03 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.